Discontinued — last reported Q2 '16
Viatris Weighted Average Exercise Price of Outstanding Options decreased by 6.6% to $31.94 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.1%, from $35.51 to $31.94. Over 5 years (FY 2020 to FY 2025), Weighted Average Exercise Price of Outstanding Options shows relatively stable performance with a -0.7% CAGR.
Higher prices relative to market value suggest lower immediate dilution risk, while lower prices indicate higher potential for future dilution.
This is the average price at which holders of outstanding stock options can purchase company shares. It provides insight...
Varies based on historical stock performance and compensation philosophy compared to industry peers.
weighted_avg_exercise_price_options_outstanding| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.09 | $37.14 | $37.19 | $38.04 | $38.25 | $38.44 | $38.53 | $37.01 | $37.15 | $37.43 | $37.41 | $35.79 | $36.03 | $35.93 | $35.94 | $35.51 | $35.86 | $35.67 | $34.21 | $31.94 |
| QoQ Change | — | +0.1% | +0.1% | +2.3% | +0.6% | +0.5% | +0.2% | -3.9% | +0.4% | +0.8% | -0.1% | -4.3% | +0.7% | -0.3% | +0.0% | -1.2% | +1.0% | -0.5% | -4.1% | -6.6% |
| YoY Change | — | — | — | — | +3.1% | +3.5% | +3.6% | -2.7% | -2.9% | -2.6% | -2.9% | -3.3% | -3.0% | -4.0% | -3.9% | -0.8% | -0.5% | -0.7% | -4.8% | -10.1% |